This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
DexCom Stock Up on Q2 Earnings & Revenue Beat, Margins Rise
by Zacks Equity Research
DXCM's Q2 earnings and revenues beat estimates as global demand, broader access and margin expansion fuel stronger 2026 guidance.
DXCMPositive Net Change CAHPositive Net Change MCKNegative Net Change PAHCNegative Net Change
earnings medical medical-devices
GMED's Q2 Earnings on Deck: Will Enabling Technologies Lead Results?
by Zacks Equity Research
Globus Medical will report Q2 results on Aug. 6. Investors will be keen to know whether Enabling Technologies and Spine strength aid revenue & earnings growth.
GMEDNegative Net Change CAHPositive Net Change CVSNegative Net Change CORNegative Net Change
medical medical-devices
MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised
by Zacks Equity Research
Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.
MMSIPositive Net Change CAHPositive Net Change MCKNegative Net Change WSTPositive Net Change
earnings medical medical-devices
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
by Zacks Equity Research
Omnicell highlights Titan XT and OmniSphere momentum, and raises profit outlook, while customer approval timing weighs on product bookings.
OMCLNegative Net Change
earnings medical-devices
BMY Q2 Earnings Call Highlights Growth Portfolio Momentum
by Zacks Equity Research
BMY highlights growth portfolio momentum, raises 2026 outlook and advances pipeline priorities as newer medicines drive results.
BMYPositive Net Change
earnings medical-devices
Cleveland-Cliffs (CLF)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CLFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AVTRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
SYK Falls Despite Q2 Earnings Beat on Strong Sales and Cyber Recovery
by Zacks Equity Research
Stryker tops Q2 estimates as sales regain momentum after a cyber disruption, but narrowed 2026 guidance weighs on shares, sending them down 7.8% in after-hours trading.
SYKNegative Net Change CAHPositive Net Change MCKNegative Net Change WSTPositive Net Change
earnings medical medical-devices
How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends
by Moumi Mondal
TMO is expanding bioproduction, AI tools and clinical data capabilities, but execution will be key as competition intensifies.
TMONegative Net Change DHRNegative Net Change ANegative Net Change
medical medical-devices
Charles River Prepares to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
CRL is set to report Q2 results on Aug. 5 as investors watch segment demand, divestitures, and whether the company can extend its earnings beat streak.
CRLNegative Net Change CAHPositive Net Change CVSNegative Net Change CORNegative Net Change
earnings medical medical-devices